Clinical and laboratory characteristics of invasive infections due to methicillin-resistant Staphylococcus aureus isolates demonstrating a vancomycin MIC of 2 micrograms per milliliter: lack of effect of heteroresistant vancomycin-intermediate S. au
about
Treatment of Gram-positive infections in critically ill patientsDissecting vancomycin-intermediate resistance in staphylococcus aureus using genome-wide association.Characterization of methicillin-resistant Staphylococcus aureus strains recovered from a phase IV clinical trial for linezolid versus vancomycin for treatment of nosocomial pneumonia.Clinical and Molecular Characterization of Invasive Heteroresistant Vancomycin-Intermediate Staphylococcus aureus Infections in Korean HospitalsClinico-microbiological study and antibiotic resistance profile of mecA and ESBL gene prevalence in patients with diabetic foot infections.Impact of reduced vancomycin MIC on clinical outcomes of methicillin-resistant Staphylococcus aureus bacteremia.Molecular Epidemiology of a Vancomycin-Intermediate Heteroresistant Staphylococcus epidermidis Outbreak in a Neonatal Intensive Care Unit.Antibiotic resistance rates in causative agents of infections in diabetic patients: rising concerns.Clinical implications of vancomycin heteroresistant and intermediately susceptible Staphylococcus aureus.
P2860
Q27015976-170A7508-C33F-470A-A3E2-FD457AA9E490Q33696380-087D7780-479A-4D29-B00D-4F6F9ACD3B37Q36363012-A934029A-3791-4ABF-9F55-B60FBAB61F04Q36620842-5E7871CA-7181-49A3-B8F8-588BECFCAA18Q36639972-B75A0DF9-ED2C-4B64-A618-D90691854947Q37263399-CA3194C1-BD29-4E2D-A486-54C711CF7D52Q37287797-E570FB32-6CC3-4083-8E1F-DAFF3548EE93Q38097122-2E118ED2-0EC0-4425-A095-3375F775E8DDQ38425879-FA1FEF98-2104-4C7B-A169-D90323198A89
P2860
Clinical and laboratory characteristics of invasive infections due to methicillin-resistant Staphylococcus aureus isolates demonstrating a vancomycin MIC of 2 micrograms per milliliter: lack of effect of heteroresistant vancomycin-intermediate S. au
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Clinical and laboratory charac ...... vancomycin-intermediate S. au
@ast
Clinical and laboratory charac ...... vancomycin-intermediate S. au
@en
type
label
Clinical and laboratory charac ...... vancomycin-intermediate S. au
@ast
Clinical and laboratory charac ...... vancomycin-intermediate S. au
@en
prefLabel
Clinical and laboratory charac ...... vancomycin-intermediate S. au
@ast
Clinical and laboratory charac ...... vancomycin-intermediate S. au
@en
P2093
P2860
P356
P1476
Clinical and laboratory charac ...... vancomycin-intermediate S. au
@en
P2093
Active Bacterial Core surveillance (ABCs) MRSA Investigators
R Lynfield
S N Bulens
S W Satola
W Schaffner
P2860
P304
P356
10.1128/JCM.01719-10
P407
P577
2011-02-16T00:00:00Z